A blood test designed to detect multiple types of cancer has passed a significant regulatory milestone, though experts say more research is still needed.
An independent panel of experts will decide whether to recommend approval of Grail's Galleri test, which the company says can detect signs of up to 50 types of cancer from a single blood draw.
An independent panel of experts has cautiously recommended approval of Grail's Galleri test, which the company says can detect up to 50 forms of cancer.
Researchers combined RNA markers with a clinically used tumor marker in an international trial aimed at catching the disease before symptoms appear.
A new blood-based test aims to identify pancreatic cancer before it reaches advanced stages, according to a report by Scientific American.